Infusion Collection
Functional recovery after neuromuscular blockade in mechanically ventilated critically ill patients
An estimated 24% to 70% of individuals have prolonged paralysis or severe weakness after receiving neuromuscular blocking agents (NMBAs) when therapy is terminated.
